Form 8-K - Current report:
SEC Accession No. 0001570562-24-000061
Filing Date
2024-04-03
Accepted
2024-04-03 16:29:58
Documents
13
Period of Report
2024-04-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K eols-20240402.htm   iXBRL 8-K 23238
  Complete submission text file 0001570562-24-000061.txt   150487

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eols-20240402.xsd EX-101.SCH 1911
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eols-20240402_lab.xml EX-101.LAB 23433
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eols-20240402_pre.xml EX-101.PRE 13588
16 EXTRACTED XBRL INSTANCE DOCUMENT eols-20240402_htm.xml XML 2729
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

EIN.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38381 | Film No.: 24819204
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)